State’s lawsuit against Purdue Pharma – unsealed
Detailed data in the state's opioid lawsuit illustrate how Purdue Pharma continued to push its most profitable drug OxyContin to high-volume providers in Tennessee despite evidence that those providers were misusing or allowing misuse of the drug, according to the state's unsealed court filing. An OxyContin tablet In one instance, Purdue called on two providers 48 times after being flagged by law enforcement; in another case, Purdue made sales calls 31 times to a provider whose license was on probation because of issues related to his high prescribing of controlled substances. The lawsuit references a wealth of evidence collected by the state to back its allegations that Purdue [...]